Causes of death among multi-drug resistant tuberculosis patients who died during treatment or follow-up, North West Province, South Africa, 2000–2008, N = 199.
Subdistribution hazard regression to identify predictors treatment initiating among patients diagnosed with RR-TB in the COJ between July 2011 and June 2012.
n = the number of rats. * Significantly different from normal group (Bonferroni's test, p† Significantly different to diabetic group, p‡ Significantly different to Normal+DiOHF group, p
ObjectiveIn clinical practice, nimodipine is used to control cerebral vasospasm (CVS), which is one of the major causes of severe disability and mortality in patients with aneurysmal subarachnoid hemo
During the run-in period, CZP will be administered at 400 mg (2 injections) at Wks 0, 2, and 4 and 200 mg with placebo (1 injection placebo, 1 injection CZP) at Wks 6, 8, 10, 12, 14 and 16. At Wk 18 p
